肌萎缩侧索硬化
鉴定(生物学)
疾病
多发性硬化
治疗方法
药理学
治疗效果
医学
治疗窗口
癌症研究
化学
生物信息学
动物模型
计算生物学
作者
Jiangli Yang,Jianyu Pang,Wenyan Li,Limin Xu,Yu Wang,Hao Zhang,Chenshi Xi,Zepeng Liu,Yuxue Zhang,Mingye Wang,Jingjing Liu,Weijian Xu,郑国庆,Shuang Chen,Xiaodong Liu,梁俊清,Kai Lei,Zhenhua Jia,Lei Gao,Chong Gao
出处
期刊:Phytomedicine
[Elsevier BV]
日期:2026-10-01
卷期号:: 158864-158864
标识
DOI:10.1016/j.phymed.2026.158864
摘要
Background Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive motor neuron degeneration, leading to muscle weakness, atrophy, fasciculations, stiffness or flaccidity, and impaired speech. Traditional Chinese Medicine associates these symptoms with deficiencies in vitality and muscle support. Shenrong Qiwei (SRQW), a formula mainly composed of Ginseng and Cistanche deserticola, has shown clinical potential for ALS, but its underlying biological mechanisms remain unclear. Purpose To evaluate the therapeutic effects of SRQW across multiple ALS models and to identify its bioactive compounds responsible for neuroprotection and neuromuscular preservation. Study Design Preclinical study combining transgenic ALS mouse models, patient-derived induced pluripotent stem cell (iPSC) neuromuscular organoids (NMOs), and iPSC-derived induced motor neurons (iMNs). Methods SRQW was administered to SOD1 and TDP43 transgenic mice to assess motor function and neuromuscular junction (NMJ) integrity. NMOs derived from ALS patient iPSCs were treated with SRQW to evaluate muscle contraction, NMJ structure, and proteinopathy. Single-nuclei RNA sequencing (snRNA-seq) was performed to assess axonal growth, synaptic activity, and ALS-related gene modulation. iMNs were used for high-throughput screening of SRQW components to identify active compounds. Results SRQW significantly improved motor performance and NMJ morphology in both SOD1 and TDP43 mice. In NMOs, SRQW enhanced muscle contraction, preserved NMJ architecture, and reduced abnormal protein accumulation. snRNA-seq indicated upregulation of genes related to axonal growth and synaptic function, along with modulation of ALS-associated genes in motor neurons. Screening in iMNs identified Ginsenoside Rg2 as the most potent bioactive component, which also ameliorated proteinopathies and restored NMJ integrity in NMOs. Conclusion SRQW exerts neuroprotective and neuromuscular benefits across multiple ALS models, with Ginsenoside Rg2 emerging as a key active compound. These findings provide mechanistic insights into the multi-component efficacy of SRQW and support its potential for translational application in ALS therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI